We are pleased to welcome another Northern Irish speaker to our Pathology Horizons panel. Dr Perry Maxwell is a superb addition to our list of global presenters.
Dr. Maxwell will discuss the importance of having a capable LIMS for the management, reporting and tracking functions of a hybrid lab that takes care of the molecular diagnostics for the whole of Northern Ireland and at the same time support the Centre of Cancer Research and Cell Biology at Queen’s University, Belfast.
In collaboration with Cirdan and Invest NI, Dr. Maxwell hopes to develop a LIMS that addresses these needs and provide clinical, research and bio bank facilities to the health service and universities across Northern Ireland. His presentation entitled, “LIMS in Modern Molecular Pathology will discuss the capabilities the LIMS needs to produce, the challenges they face with function complexity, along with the benefits it will deliver to not only lab management but to quality research and clinical services.
Dr Perry Maxwell is an Honorary Senior Lecturer at Queen’s University Belfast (QUB) and until March of this year was the Lead Clinical Scientist for Molecular Pathology Diagnostics in the Northern Ireland Molecular Pathology Laboratory (NI MPL), Belfast, UK. NI MPL is a hybrid laboratory that is accredited in the UK to take care of the molecular diagnostics of the whole of NI and, at the same time, support the translational research mission of the Centre for Cancer Research and Cell Biology, Queen’s University, Belfast.
View Pathology Horizons 2017 agenda.